Live Breaking News & Updates on Apogee therapeutics

Stay updated with breaking news from Apogee therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Artia Global Partners LP Makes New $290,000 Investment in Apogee Therapeutics, Inc. (NASDAQ:APGE)

Artia Global Partners LP bought a new position in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 10,381 shares of the company’s stock, valued at approximately $290,000. Apogee Therapeutics makes up approximately 0.1% of […] ....

Wellington , New-zealand-general , New-zealand , United-states , America , Stifel-nicolaus , Apogee-therapeutics-inc , Nasdaq , Jefferies-financial-group , Wellington-management-group , Vanguard-group-inc , Artia-global-partners

Artia Global Partners LP Acquires New Stake in Apogee Therapeutics, Inc. (NASDAQ:APGE)

Artia Global Partners LP acquired a new position in Apogee Therapeutics, Inc. (NASDAQ:APGE – Free Report) during the 4th quarter, HoldingsChannel.com reports. The firm acquired 10,381 shares of the company’s stock, valued at approximately $290,000. Apogee Therapeutics makes up 0.1% of Artia Global Partners LP’s holdings, making the stock its 25th largest holding. Other large […] ....

United-states , Wellington , New-zealand-general , New-zealand , America , Stifel-nicolaus , Jefferies-financial-group , Apogee-therapeutics-inc , Nasdaq , Vanguard-group-inc , Wellington-management-group , Artia-global-partners

Swiss National Bank Makes New $922,000 Investment in Apogee Therapeutics, Inc. (NASDAQ:APGE)

Swiss National Bank bought a new stake in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 33,000 shares of the company’s stock, valued at approximately $922,000. Swiss National Bank owned approximately 0.07% of […] ....

Switzerland , New-york , United-states , China , America , Swiss , Stifel-nicolaus , Nasdaq , Vanguard-group-inc , China-universal-asset-management-co , Sg-americas-securities , York-state-common-retirement-fund

CinCor's 'hub-and-spoke' parent nabs new funding to build its next biotechs

CinCor's 'hub-and-spoke' parent nabs new funding to build its next biotechs
biopharmadive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biopharmadive.com Daily Mail and Mail on Sunday newspapers.

Ohio , United-states , Cinfina-pharma , Cinphloro-pharma , Jon-isaacsohn , Cincor-pharma , Cindome-pharma , Puretech-health , Astrazeneca , Roivant-sciences , Johnson , Dive-brief

Viking, CRISPR, Cytokinetics are M&A targets: Wells Fargo

Viking, CRISPR, Cytokinetics are M&A targets: Wells Fargo
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Moonlake-immunotherapeutics , Arcutis-biotherapeutics , Zealand-pharma , Verona-pharma , Bridgebio-pharma , Mohit-bansal , Neurocrine-biosciences , Iovance-biotherapeutics , Wells-fargo , Alnylam-pharmaceuticals , Rhythm-pharmaceuticals , Apellis-pharmaceuticals